13.2.2026
SL Insight Newsletter #19
TrumpRx live: Discount channel as MFN component
Marcel Boller
On February 5, 2026, the US administration launched TrumpRx.gov: a government portal that directs patients to cash payment channels (including coupons) for selected brand-name drugs. At launch, 40 products from the first five deal companies (including Novo Nordisk, Pfizer, Lilly, AstraZeneca, and EMD Serono) are listed.
Impact on Switzerland?
The new, publicly visible US "cash price" channel for individual blockbusters is relevant for Switzerland: it can act as an additional price anchor in global reference discussions, thereby intensifying the negotiation dynamics (APV/TQV) and the tone of 3-year reviews. At the same time, the model remains selective and voluntary – in practice, the FOPH will have to be measured against whether and how such DTC discounts can be reliably used as "comparable" prices.
